Mostrando 3 resultados de: 3
Filtros aplicados
Subtipo de publicación
Article(3)
Publisher
European Journal of Endocrinology(1)
Journal of Clinical Endocrinology and Metabolism(1)
The Lancet Diabetes and Endocrinology(1)
Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase
ArticleAbstract: Background: Cushing's disease is a rare endocrine disorder characterised by cortisol overproductionPalabras claves:Autores:Bertagna X., Biller B.M.K., Findling J.W., Fleseriu M., Gu F., Kim J.H., Lacroix A., Laplanche A., Lee E.J., Leelawattana R., Newell-Price J., O'Connell P., Pedroncelli A.M., Pivonello R., Richard J. Auchus, Shimatsu A., Tauchmanova L.Fuentes:scopusLong-term outcomes of osilodrostat in Cushing’s disease: LINC 3 study extension
ArticleAbstract: Objective: To investigate the long-term efficacy and tolerability of osilodrostat, a potent oral 11βPalabras claves:Autores:Belaya Z., Biller B.M.K., Feelders R.A., Fleseriu M., Houde G., Izquierdo M., Newell-Price J., Pedroncelli A.M., Pivonello R., Richard J. Auchus, Roughton M., Scaroni C., Shimatsu A., Vila G., Walia R.Fuentes:scopusRandomized Trial of Osilodrostat for the Treatment of Cushing Disease
ArticleAbstract: Context: Cushing disease, a chronic hypercortisolism disorder, is associated with considerable morbiPalabras claves:11β-hydroxylase, Cushing disease, Hypercortisolism, OsilodrostatAutores:Belaya Z., Bex M., Carvalho D., Feelders R.A., Gadelha M., Gilis-Januszewska A., Heaney A.P., Ku C.H.C., Liao Z., Pedroncelli A.M., Richard J. Auchus, Roughton M., Snyder P.J., Witek P., Wojna J., Yu Y.Fuentes:scopus